ELV
Elevance Health Inc.
Dividend Growth | |
| Min. Div. Growth Past 7 Yrs. ≥ 15%: 13.4% | |
| Rolling 4-Yrs Div. Growth Past 7 Yrs ≥ 15%: 13.7% | |
| Years of Div. Growth ≥ 15: 13 | |
Income Generation | |
| Current Yield 1.6% ≥ 20-Yrs Treasury Yield 4.7% | |
| Total Dividends ≥ 20-Yrs Treasury Coupons in 5 Yrs | |
Sustainability | |
| Debt-To-Equity 0.40 ≤ 0.45 | |
| Last 12Months Cash Payout 1.77 ≤ 0.6 | |
Profitability | |
| 5-Yr Avg. Return-on-Equity 16.0% ≥ 15% | |
| Last 12Months Return-on-Equity 16.6% ≥ 15% | |
| Last 12Months Net Profit Margin 3.9% ≥ 10% | |
Fair Value | |
| Average 5-Yrs High Yield 1.6% | |
| Current Price $400.7 ≤ High Yield Price $410.1 | |
| Average 5-Yrs Price-to-Earning (P/E) 16.2 | |
| Current Price $400.7 ≤ Average P/E Price $460.6 | |
| Current Price $400.7 ≤ Fair Value $341.4 |
Company Description
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Dividend
Revenue
Earning
Free Cash Flow